Cryopreservation effect on proliferative and chondrogenic potential of human chondrocytes isolated from superficial and deep cartilage by Muíños López, Emma et al.
150 The Open Orthopaedics Journal, 2012, 6, 150-159  
 
 1874-3250/12 2012 Bentham Open 
Open Access 
Cryopreservation Effect on Proliferative and Chondrogenic Potential of 
Human Chondrocytes Isolated from Superficial and Deep Cartilage 
Emma Muiños-López1,2, Mª Esther Rendal-Vázquez3, Tamara Hermida-Gómez1,2,  
Isaac Fuentes-Boquete1,4, Silvia Díaz-Prado1,4 and Francisco J. Blanco*,1,2,5 
1
CIBER-BBN-Cellular Therapy Area, Spain 
2
Rheumatology Division, INIBIC-Hospital Universitario A Coruña, A Coruña, Spain 
3
Tissue Bank, INIBIC-Hospital Universitario A Coruña, A Coruña, Spain 
4
Department of Medicine, INIBIC-Universidad de A Coruña, Spain 
5
Department of Medicine, Universidad de Santiago Compostela, Spain 
Abstract: Objectives: To compare the proliferative and chondrogenic potential of fresh and frozen chondrocytes isolated 
from superficial and deep articular cartilage biopsies. 
Materials and Methodology: The study included 12 samples of fresh and frozen healthy human knee articular cartilage. 
Cell proliferation was tested at 3, 6 and 9 days. Studies of mRNA quantification, protein expression and 
immunofluorescence for proliferation and chondrogenic markers were performed. 
Results: Stimulation of fresh and frozen chondrocytes from both superficial and deep cartilage with fetal bovine serum 
produced an increase in the proliferative capacity compared to the non-stimulated control group. In the stimulated fresh 
cells group, the proliferative capacity of cells from the deep biopsy was greater than that from cells from the superficial 
biopsy (0.046 vs 0.028, respectively, p<0.05). There was also a significant difference between the proliferative capacity of 
superficial zone fresh (0.028) and frozen (0.051) chondrocytes (p<0.05). CCND1 mRNA and protein expression levels, 
and immunopositivity for Ki67 revealed a higher proliferative capacity for fresh articular chondrocytes from deep 
cartilage. Regarding the chondrogenic potential, stimulated fresh cells showed higher SOX9 and Col II expression in 
chondrocytes from deep than from superficial zone (p<0.05, T student test). 
Conclusions: The highest rate of cell proliferation and chondrogenic potential of fresh chondrocytes was found in cells 
obtained from deep cartilage biopsies, whereas there were no statistically significant differences in proliferative and 
chondrogenic capacity between biopsy origins with frozen chondrocytes. These results indicate that both origin and 
cryopreservation affect the proliferative and chondrogenic potential of chondrocytes. 
Keywords: Autologous chondrocyte implantation, cartilage, cell therapy, osteoarthritis. 
INTRODUCTION 
 The limited ability of articular cartilage to repair arises 
from its avascular nature [1-3]. Consequently, progenitor 
cells in blood and marrow cannot enter a damaged region to 
influence or contribute to the repair process [4]. There are 
three categories of joint damage according to their 
characteristics: 1) minor damage or repeated trauma of the 
matrix and cells, 2) surface damage or chondral fracture or 
damage that do not penetrate the subchondral bone, and 3) 
osteochondral damage that penetrate the subchondral bone 
[5]. Reliable techniques and methods for stimulating growth 
of new cartilage tissue to treat degenerative diseases and 
trauma are lacking [6]. At present, most techniques for 
repairing injuries of articular cartilage aim to overcome its 
limitations for healing injuries by facilitating access of the  
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vascular system to the injury [2]. However, these techniques 
generate a fibrocartilaginous repair tissue that lacks both the 
structure and function of natural hyaline articular cartilage. 
To avoid the need for prosthetic replacement, cell treatments 
have been developed that attempt to generate repair tissue 
with the structure, biochemical composition and function 
similar to natural articular cartilage [7]. 
 Cell therapy using autologous chondrocyte implantation 
(ACI) to repair focal defects of articular cartilage, obtains a 
repair tissue of higher quality compared to fibrocartilage 
tissue [7-16]. This therapeutic procedure is used clinically in 
combination with a periostial cover to treat chondral or 
osteochondral defects of the knee, with good clinical results 
[4]. ACI involves obtaining articular cartilage explants by 
arthroscopy from areas not under load. Chondrocytes 
isolated from these cartilage biopsies are cultured in the 
laboratory under in vitro conditions until an adequate 
number of cells for implantation into the chondral defect is 
obtained [17]. However, ACI has some limitations [18-27], 
such as basal and peripheral integration, inadequate fill, 
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fibrous, rather than hyaline repair, etc. Moreover, the 
proliferation and chondrogenic potential of chondrocytes is 
also an important limitation in the ACI practise. 
 The senescence of human articular chondrocytes reduces 
their proliferative capacity in vitro. Proliferating cell nuclear 
antigen (PCNA), cyclin D1 (CCND1) and Ki67 are 
molecular markers with predictive capacity for cell 
proliferation. PCNA is expressed exclusively in actively 
proliferating cells but not in non-cycling cells [28]. CCND1 
belongs to a regulatory proteins family that drive the ordered 
progression of mammalian cells through critical transition 
points in the cell division cycle. The D-type cyclins control 
the passage of cells through the G1 phase, allowing entry 
into the S phase. Furthermore, assessment of cell 
proliferation by detecting the Ki67 antigen in cell 
populations has been used to determine a wider range of 
dividing cells. Ki67 antigen is co-expressed during late G1, 
S, G2, and M phases, allowing for a wider range of 
proliferating cell populations than cyclin D1 [29]. But 
success cell therapy or tissue engineering do not reside just 
in the proliferative capacity, chondrogenic potential is also 
critical. Col II (type II collagen), that encodes a key 
cartilage-specific extracellular matrix protein [30], and SOX9 
(SRY sex determining region-Y-box 9), that encodes a 
nuclear transcription factor [31], are two molecular markers 
predictive of the chondrogenic potential of human articular 
chondrocytes cultured in monolayer. SOX9 is required for 
the deposition of cartilage matrix containing collagens II, IX, 
XI and aggrecan [32]. This transcription factor is expressed 
continuously in chondrocytes up to the hypertrophic stage 
[33]. In this regard, the main objective of this study was to 
compare the proliferative and chondrogenic potential of fresh 
and frozen chondrocytes isolated from superficial and deep 
articular cartilage biopsies. 
MATERIALS AND METHODOLOGY 
Sample Processing and Cell Culture Techniques 
Collection and Obtaining of Articular Cartilage Samples 
 The Ethic Committee of Clinical Investigation of Galicia 
approved this study. Samples of knee articular cartilage were 
provided by the Autopsy Service at CHU A Coruña (Spain). 
Cartilage sections (N=12) were dissected from the femoral 
condyles and tibial plate of each knee articular cartilage 
under sterile conditions and washed with Dulbecco's 
Modified Eagle's Medium (DMEM) (Gibco, Life 
Technologies, Paisley, Scotland) supplemented with 
penicillin (100 units/ml) and streptomycin (100 μg/ml) 
(Gibco Invitrogen, Grand Island, NY, USA). From each 
specimen, superficial and deep cartilage samples were 
separated, minced with a scalpel and transferred to a 
digestion buffer containing 1% trypsin (Sigma-Aldrich, St. 
Louis, MO, USA) for 15 min at 37ºC. Superficial cartilage 
comprised 0.5 mm thickness and was obtained in a single 
layer from one of the condyles, the remaining cartilage was 
considered as deep cartilage. Therefore, deep cartilage 
comprised a mixture of chondrocytes from the middle and 
deep zones of cartilage. Regarding the superficial and deep 
cartilage, around 100,000 cells were successfully isolated per 
gram of tissue with a 90% viability. All superficial and deep 
cartilage biopsies were analyzed by hematoxylin-eosin  
 
staining in order to determine the correct selection of the 
layers. Following removal of trypsin, the cartilage samples 
were incubated for 12 to 16 h in a digestion solution 
containing 5 CDU (collagen digestion units) type IV 
collagenase (Sigma-Aldrich, St Louis, MO). After this 
digestion solution was removed, the cells were washed with 
DMEM and centrifuged at 200xg for 10 minutes. The 
number of isolated chondrocytes was counted using a 
Neubauer Chamber and 0.4% trypan blue dye (Sigma-
Aldrich, St Louis, MO, USA) to assess viability. Four 
aliquots with equal numbers of cells were separated, two 
each from superficial and deep cartilage (Fig. 1). One aliquot 
of cells from each superficial and deep cartilage sample was 
cultured in DMEM with 10% fetal bovine serum (FBS) to 
perform cell proliferation assays. The other two aliquots of 
cells from superficial and deep cartilage samples were 
cryopreserved at -196°C for 3 months following the 
controlled freezing program. For controlled freezing we used 
freezing rates of 1ºC/min to a temperature of -40ºC, 2ºC/min 
to -60ºC, and 5ºC/min to -150ºC. The equipment used for 
controlled freezing was CM 25 (Carburos Metálicos, 
Barcelona, Spain). For thawing protocol we introduced the 
freeze aliquot on a heat-bath at 37ºC. After thawing, cells 
were introduced in a tube with DMEM plus 10% FBS and 
centrifuged at 200xg for 10 min. These chondrocytes were 
cultured, then, following two sub-cultures, the same 
proliferation studies described above for fresh chondrocytes 
were performed. 
Chondrocyte Culture 
 Chondrocytes were cultured in 25 cm2 culture flasks with 
DMEM supplemented with 100 units/ml penicillin, 100 
μg/ml streptomycin, 1% glutamine and 10% FBS (Gibco, 
Life Technologies) in a humidified 5% CO2 atmosphere at 
37ºC (Steri-Cult 200 Incubator HEPA class 100, Hucoa 
Erlöss, Madrid, Spain). Two weeks later, when confluency 
was attained, the cells were sub-cultured and used for 
proliferation studies. 
Cell Proliferation Assays 
 Cells, grown on DMEM with 10% FBS at passage 1, 
from both superficial and deep cartilage samples were placed 
in 12-well plates (Corning Incorporated, Corning, NY, USA) 
at 5x104 cells per well (1ml per well) and cultured in DMEM 
medium without FBS for 24 hours. The culture medium was 
then removed and the cells were stimulated by culturing with 
DMEM with 10% FBS (Sigma-Aldrich, St. Louis, MO, 
USA). For the control cultures, DMEM without FBS was 
used. At 3, 6 and 9 days after stimulation, cells were washed 
with 1% phosphate-buffered saline (PBS) and fixed with 4% 
paraformaldehyde for 15 minutes. Following 
paraformaldehyde removal, two washes with 1% PBS were 
performed before adding 0.5% toluidine blue for 15 minutes. 
The toluidine blue was then removed and the cells were 
again washed with 1% PBS to remove unbound dye. The 
cells were solubilized with 1.5 ml of 1% SDS and the 
absorbance was read on a spectrophotometer at 570 nm. The 
results shown in the graphs represent the differences in 
absorbance obtained for samples cultured in DMEM with 
10% FBS relative to the control culture in DMEM without 
FBS at each time point. Each value represents the average of 
two independent experiments. 
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Molecular Biology Techniques 
RNA Extraction 
 Isolation of total RNA from cultured cells was performed 
using Trizol Reagent (Invitrogen, Madrid, Spain), following 
the manufacturer´s protocol. From each cell culture, 106 cells 
were obtained for RNA isolation. Total RNA was further 
processed by reverse transcriptase-polymerase chain reaction 
(RT-PCR) or stored at -80ºC until used. RNA integrity was 
confirmed using 2% agarose gel electrophoresis stained with 
ethidium bromide. RNA also was assessed for quantity at 
260 nm using a NanoDropTM spectrophotometer (Fisher 
Scientific, Madrid, Spain). The A260/A280 ratio was 
calculated for quality and purity. 
cDNA Synthesis 
 RT-PCR was performed from 1 g of total RNA using 
SuperScriptTM First-Strand Synthesis System for RT-PCR 
(Invitrogen, Madrid, Spain) to a total volume of 20 l in a 
Thermocycler (Gene Amp PCR System 9700, Applied 
Biosystem, Madrid, Spain). 1 g of total RNA, 2.5 nM 
random hexamers, 0.5 mM of dNTP mix, and 3 l of DEPC-
treated water were denatured at 65ºC for 5 minutes and 
chilled on ice for at least 1 minute. 2 l of 10xRT buffer, 5 
mM MgCl2, 0.01 M DTT, and 40 U of RNaseOUT 
Recombinant Ribonuclease Inhibitor were mixed, collected 
by centrifugation, and incubated at 25ºC for 2 minutes. After 
incubation, 50 U of SuperScriptTM RT were added and 
incubated at 25ºC for 10 minutes, 42ºC for 50 minutes and 
70ºC for 15 minutes in a Thermocycler. Finally, samples 
were chilled on ice and incubated with 2 U of RNAse H for 
20 minutes at 37ºC before proceeding to amplification of the 
target cDNA. Samples were stored at -20ºC before the 
cDNA target was amplified. Positive and negative controls 
were included in each experiment. RNA extraction, reverse 
transcription-PCR assay setup and post-reverse transcription-
PCR product analysis were carried out in separate dedicated 
rooms to prevent cross-contamination. 
Quantitative Real-Time Reverse Transcriptase-PCR 
Analysis (qRT-PCR) 
 qRT-PCR analysis was performed using the primers and 
conditions shown in Table 1. A LightCycler® 480 
Instrument (Roche, Mannheim, Germany) using the 
LightCycler 480 SYBR Green I Master (Roche, Mannheim, 
Germany) was employed. The PCR reaction consisted of 10 
l of Master Mix 2x conc., 0.35 M of each forward and 
reverse primer, the cDNA template (obtained by reverse-
transcripton from 1g RNA) and PCR-grade water up to a 
final volume of 20 l in the LightCycler 480 Multiwell Plate 
96. This multiwell plate was centrifuged at 1500xg for 2 
minutes and was loaded in the LightCycler 480 Instrument 
until the PCR program started. An initial activation at 95ºC 
for 5 minutes was followed by an amplification target 
 
Fig. (1). Study design. 
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sequence of 50 cycles at 95ºC for 10s, 60ºC for 10s, and 
72ºC for 7s. For melting curve analysis, 1 cycle at 95ºC for 
5s, 70ºC for 15s, and 95ºC for 1s was used. The final step 
was cooling at 40ºC for 10s. We verified that the 
amplifications and the expected size of each PCR product 
were specific. 1.8% agarose gel electrophoresis of all PCR 
products revealed a single band that corresponded to the 
single-amplified products as predicted by the melting curve 
analysis of the PCR. PCR primers for mRNA amplification 
were carefully designed using the web-based ProbeFinder 
software (Universal ProbeLibrary Design Center) accessible 
at [34] or via Roche Applied Science home page [35]. PCR 
primers have been positioned to span exon-intron 
boundaries, reducing the risk of detecting genomic DNA. 
Primers were purchased from Roche (Mannheim, Germany). 
The selection of a suitable housekeeping gene was made 
using the Human Endogenous Control Gene Panel (TATAA 
Biocenter, Göteborg, Sweden). The Excel macro named 
GeNorm VBA applet for Microsoft Excel available at [36] 
was used to determine the gene(s) with most correlated 
expression in the set of samples. The selected housekeeping 
gene, HPRT (hypoxanthine-guanine phosphoribosyltrans-
ferase), was used as internal control as well as to verify the 
integrity of the RNA and efficacy of reverse transcription. 
Any specimen with inadequate housekeeping HPRT mRNA 
was excluded from the study. Data analysis was performed 
using LightCycler 480 Relative Quantification software 
(Roche, Mannheim, Germany). Relative levels of expression 
were calculated by the 2-Ct method of [37]. Each assay was 
done at least in triplicate and included marker-positive and 
marker-negative controls and reagent with no template 
controls. Data were normalized against the lowest value 
obtained for each gene, which was assigned the value of 1, 
and were measured as relative expression levels (R.E.L). 
DNA Sequencing Analysis 
 At least one PCR product coming from each qRT-PCR 
experiment was used as DNA template in order to verify the 
specificity of the amplified amplicon. PCR products were 
purified by an enzymatic method (ExoSAP-IT, Amersham 
Biosciences, Madrid, Spain). DNA sequencing was performed 
in a reference facility on ABI 3100 (Applied Biosystems, 
Madrid, Spain) using Big Dye terminators. Forward and reverse 
specific primers were used (these primers were the same as for 
the qRT-PCR experiments, see Table 1). 
 Standard procedures for manipulation of nucleic acids 
were essentially those of [38]. 
Western Blot 
 Cultured cells were washed in ice cold PBS, pH 7.5, and 
lysed in 0.2 M Tris-HCl, pH 6.8, containing 2% SDS 
(sodium dodecyl sulphate), 20% glycerol, 1 μg/ml inhibitor 
cocktail, and 1 mM PMSF (phenyl methyl sulphonyl fluoride 
(Sigma-Aldrich, St Louis, MO, USA) buffer. Samples were 
boiled at 100ºC for 5 minutes. Protein concentrations were 
measured using a NanoDropTM spectrophotometer (Fisher 
Scientific, Madrid, Spain). 30 g of protein extract per well 
was resolved on 10% SDS-polyacrylamide gel and 
transferred to polyvinylidene difluoride membranes 
(Immobilon P, Millipore Co, Bedford, MA, USA). The 
membranes were blocked in 10 mM Tris-HCl pH 7.5, 
containing 100 mM NaCl, 1% Tween 20, and 5% non-fat 
dried milk for 1 hour at room temperature (RT) and then 
incubated overnight with mouse anti-human Cyclin D1 (BD 
Biosciences, Madrid, Spain) in fresh blocking solution at 
4ºC. After several washes, CCND1 protein was detected by 
incubation with a secondary antibody, ECL anti-mouse IgG 
horseradish peroxidase-linked whole antibody (GE 
Healthcare Life Science, Buckinghamshire, UK). To confirm 
that equal amounts of total proteins were charged, each 
membrane was incubated with anti--tubulin (Sigma-Aldrich 
Quimica, Madrid, Spain). Data were normalized against the 
lowest value obtained for CCND1 protein expression levels, 
assigned the value of 1, and were measured as R.E.L. 
Immunofluorescence and Immunohistochemical Tech-
niques 
 Frozen and deparaffinized and hydrated paraffin sections 
(4 μm thick) were incubated with anti-human Ki67 antibody 
(Novocastra, Newcastle, UK). For immunofluorescence 
analysis, goat anti-mouse-retinal pigment epithelium (RPE) 
(Dako Diagnósticos, Barcelona, Spain) was used as a 
secondary antibody. Cells were counterstained with the 
nuclear fluorophore, DAPI (4 ', 6-diamidino-2-phenylindole, 
dihydrochloride) (Invitrogen, Madrid, Spain). For 
immunohistochemical studies, the Kit EnvisionTM Detection 
Systems Peroxidase/DAB Rabbit/Mouse (Dako Diagnós-
ticos, Barcelona, Spain) was used to determine antigen-
antibody interactions. Negative controls were created by 
omitting the primary antibody. 
Table 1. Primer Sequences, Conditions and Annealing Temperature of qRT-PCR Assays 
 
Primers Sequence Length %GC Annealing Temperature Amplicon (bp) Reference 
CCND1 1F 5´ gac ctt cgt tgc cct ctg t 3´ 19 mer 58 
CCND 1R 5´ ggt tca ggc ctt gca ctg 3´ 18 mer 61 
60ºC 101 Universal ProbeLibrary 
SOX9 2F 5´gtacccgcacttgcacaac 3´ 19 58 
SOX9 2R 5´ tcgctctcgttcagaagtctc 3´ 21 52 
60ºC 72 Universal ProbeLibrary 
COL II 3F 5´ gtgtcagggccaggatgt 3´ 18 61 
COL II 3R 5´ tcccagtgtcacagacacagat 3´ 22 50 
60ºC 116 Universal ProbeLibrary 
HPRT 1F 5´ tga cct tga ttt att ttg cat acc 3´ 24 mer 33 
HPRT 1R 5´ cgagcaagacgttcagtcct 3´ 20 mer 55 
60ºC 102 Universal ProbeLibrary 
CCND1 = cyclin D1; SOX9 = SRY (sex determining region-Y)-box 9; COL II = type II collagen; HPRT = Hypoxanthine-guanine phosphoribosyltransferase. 
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 Quantification of the cells positive for Ki67 was 
performed using analiSIS® software (version D; Olympus, 
Barcelona, Germany). The percentage of positive cells for 
Ki67 was assessed counting the same number of cells in both 
cartilage zones, comparing sample to sample, and always 
respecting the same area of analysis of the samples. 
Quantification using the software must be coincident with 
the microscopic screening. The nuclear size of positive cells 
was taken into account, i.e. there was no greater percentage 
of positivity as a greater nuclear size, since differences 
between cells have been respected. 
Statistical Analysis 
 All statistical analyses were performed using SPSS 16.0 
software for Windows, p values <0.05 were considered 
statistically significant. 
RESULTS 
Cell Proliferation Assays of Fresh and Frozen 
Chondrocytes from Superficial and Deep Human Knee 
Articular Cartilage Biopsies 
 Comparisons were made between fresh and frozen cells 
from superficial and deep cartilage biopsies, without 
considering time post-stimulation. In stimulated fresh cells 
from both superficial and deep cartilage, there was an 
increase in the proliferative capacity of chondrocytes 
compared to the non-stimulated controls. After stimulation, a 
significantly higher proliferative capacity (0.046) was found 
for fresh chondrocytes from the deep zone biopsies than for 
those from the superficial zone (0.028) (p<0.05, Mann-
Whitney U test) (Fig. 2). The stimulated frozen cells from 
both biopsy locations also showed an increase in 
proliferative capacity compared to the non-stimulated 
controls. Stimulated frozen cells showed no significant 
difference in proliferative capacity between chondrocytes of 
deep (0.043) and superficial (0.051) zone origin. There was a 
significant difference between the proliferative capacity of 
superficial zone fresh (0.028) and frozen (0.051) 
chondrocytes (p<0.05, Mann-Whitney U test) (Fig. 2). 
mRNA Quantification of Proliferative and Chondrogenic 
Markers in Fresh and Frozen Chondrocytes from 
Superficial and Deep Human Knee Articular Cartilage 
Biopsies 
 In this study, using quantitative analysis of CCND1 
mRNA expression levels by qRT-PCR, the cell proliferation 
of fresh and frozen chondrocytes from superficial and deep 
cartilage biopsies were examined. The highest expression 
levels of CCND1 mRNA were obtained in fresh cells from 
deep cartilage biopsies (4.36 R.E.L.). Fresh (3.63 R.E.L.) 
and frozen (3.66 R.E.L.) cells from superficial cartilage 
biopsies showed equal expression, whereas frozen cells from 
deep cartilage biopsies showed the lowest expression levels 
for CCND1 (3.41 R.E.L.). Statistical analyses determined 
there was no significant differences in CCND1 mRNA 
expression levels between superficial and deep zone biopsies 
either from fresh or frozen chondrocytes. There was a trend 
toward a higher expression of the CCND1 gene in fresh cells 
from deep cartilage biopsies that did not achieve statistical 
significance (Fig. 3A). 
 
Fig. (2). Cell proliferation assays: Comparison of the overall 
proliferative capacity of fresh and frozen cells related to the 
superficial or deep origin of the articular cartilage biopsy. Fresh or 
frozen human knee superficial and deep articular cartilage 
chondrocytes were stimulated by culturing with Dulbecco's 
Modified Eagle's Medium (DMEM) with 10% fetal bovine serum 
(FBS). Following staining with toluidine blue, the cells were 
solubilized and the absorbance was determined. The results 
represent the differences in absorbance for stimulated cells relative 
to the control culture in DMEM without FBS at the same time 
point. * p<0.05. 
 Moreover mRNA quantitative analyses for chondrogenic 
markers, SOX9 and Col II, were developed. The highest 
expression levels of SOX9 mRNA were obtained in fresh cells 
from deep cartilage biopsies (Fig. 3B). Stimulated fresh cells 
showed higher SOX9 expression in chondrocytes from deep 
(1.32 R.E.L.) than from superficial (0.92 R.E.L.) zone (p<0.05, 
T student test). There was a significant difference between the 
SOX9 mRNA expression of fresh (0.92 R.E.L.) and frozen (0.56 
R.E.L.) chondrocytes from superficial origin (p<0.05, T student 
test). Regarding chondrocytes from deep cartilage we found 
statistical significant differences comparing fresh (1.32 R.E.L.) 
and frozen (0.66 R.E.L.) chondrocytes. 
 Col II quantitative analyses showed higher expression levels 
in fresh cells from deep cartilage biopsies (Fig. 3C). In this 
regard, stimulated fresh cells showed higher Col II expression in 
chondrocytes from deep (1378 R.E.L.) than from superficial 
(54.07 R.E.L.) zone (p<0.05, T student test). Regarding 
chondrocytes from deep cartilage we also found statistical 
significant differences in Col II mRNA expression comparing 
fresh (1378 R.E.L.) and frozen (84.03 R.E.L.) chondrocytes. 
Analysis of CCND1 Protein Expression Levels of Fresh 
and Frozen Chondrocytes from Superficial and Deep 
Human Knee Articular Cartilage Biopsies 
 To validate the results obtained with cell proliferation 
assays and qRT-PCR, the protein expression levels of 
CCND1 in the four different groups of cells were examined 
(Fig. 4). The highest protein expression levels of CCND1 
were obtained from fresh cells from both deep (2.09 R.E.L.) 
and superficial (1.98 R.E.L.) cartilage biopsies. The values 
obtained for frozen chondrocytes from deep (1.88 R.E.L.) 
and superficial (1.76 R.E.L) cartilage were the lowest. These 
results for CCND1 gene expression for fresh chondrocytes 
from deep cartilage were confirmed by western blot. 
Immunofluorescence and Immunohistochemical Analysis 
of Predictive Markers for Proliferative Capacity of 
Human Knee Articular Chondrocytes 
 Histological studies of normal human knee articular 
cartilage tissue using immunofluorescence and immuno-
histochemical analysis showed more positive cells for Ki67 


%&' %&
%()
%*
++

%
%(
%
%&
%*
%'
%,
%)
--"."-$$/0

$
-

-
1

-


2

2


-

.

Proliferative Capacity of Chondrocytes The Open Orthopaedics Journal, 2012, Volume 6    155 
(Fig. 5) in deep (0.59%±0.19) than in superficial 
(0.11%±0.09) cartilage (p<0.05). 
DISCUSSION 
 Throughout life, articular cartilage is exposed to 
exogenous mechanical stresses. These mechanical forces on 
joints can exceed the limit tolerated by cartilage structures, 
causing erosion with the loss of material from solid surfaces. 
Additional mechanical factors that can exacerbate cartilage 
erosion or accelerate its evolution include defective joint 
structures and functional wear from professional or sport 
activities, and obesity [39]. To date, most efforts made to 
repair an articular cartilage injury have been aimed at 
overcoming limitations of this tissue for healing through the 
introduction of new cells with chondrogenic capacity [40], or 
facilitation of access to the vascular system. However, none 
 
Fig. (3). mRNA quantification of proliferative and chondrogenic markers expressed by fresh and frozen cells in superficial and deep origin 
articular cartilage biopsies. Fresh or frozen human knee superficial and deep articular cartilage chondrocytes were stimulated by culturing 
with Dulbecco's Modified Eagle's Medium (DMEM) with 10% fetal bovine serum (FBS). qRT-PCR was performed to determine the 
expression of CCND1 [A], SOX9 [B] and Col II [C] mRNA. The data were normalized against the lowest value obtained for each marker 
assessed which was assigned the value of 1, and were measured as relative expression levels (R.E.L). *p<0.05. 
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of the numerous treatments now available consistently 
regenerates normal hyaline cartilage. Current treatments 
generate a fibrocartilaginous tissue that differs structurally 
and functionally from hyaline articular cartilage. 
 Cell therapy is a new clinical approach for the repair of 
damaged tissues. A cell-based therapeutic alternative 
offering more effective repair of focal articular cartilage 
defects is autologous chondrocyte implantation (ACI) which 
was developed in a rabbit experimental model [41]. The first 
clinical application of this method was performed by the 
group of Brittberg [16], which also demonstrated the 
successful repair of articular cartilage in rabbits transplanted 
with autologous chondrocytes [42]. Currently the ACI is 
proving to be one of the most safe and effective therapies for 
treatment of focal defects in articular cartilage [7-16, 43, 44]. 
Cell therapy is most successful in young people, yielding 
repair tissue of high quality [13, 16]. ACI offers the 
advantage of using cells that are stably committed to the 
appropriate phenotype and naturally resistant to vascular 
invasion, mineralization and ossification [23]. It is used 
successfully in patients with a particular profile, young 
people without damage in other joints [45, 46]. ACI is based 
on the capability of chondrocytes to proliferate in vitro [46]. 
Previous in vitro studies demonstrated a marked decrease of 
chondrocyte proliferation and lowered phenotypic stability to 
be a function of increasing donor age [28, 46], resulting in a 
tissue that is less able to maintain homeostasis when 
stressed, leading to a breakdown and loss of articular 
cartilage, a hallmark of osteoarthritis [47]. The capacity for 
cell proliferation of chondrocytes is the most important 
limitation of ACI [7, 18-27, 48]. This proliferative capacity 
depends not only on donor age, but also on the conditions 
used to preserve the chondrocytes until the time of implant 
[49]. 
 This trial was designed to study whether the proliferative 
and chondrogenic capacity of chondrocytes is dependent on 
their origin, i.e., superficial or deep cartilage biopsies, and 
the conditions of their culture and preservation, fresh or 
cryopreserved. The results demonstrate differences between 
the proliferative capacities of chondrocytes from superficial 
and deep articular cartilage biopsies; fresh chondrocytes 
from deep biopsies showed greater proliferative capacity 
than fresh chondrocytes from superficial cartilage. These 
differences were confirmed by CCND1 mRNA and protein 
detection, which also found increased proliferative capacity 
of fresh human articular chondrocytes from deep cartilage 
biopsies. Immunofluorescence and immunohistochemical 
studies for Ki67 detection found higher protein expression 
for this marker in deep cartilage. Similar results were 
obtained for the PCNA marker showing a tendency toward 
more positivity in deep cartilage than in superficial samples 
(data not shown). As both markers Ki67 and PCNA are 
potential predictive markers for proliferative capacity of 
human articular chondrocytes [28, 29, 50, 51] these results 
support the idea that chondrocytes from deep zone have 
higher proliferative capacity. Regarding the chondrogenic 
potential, stimulated fresh cells also showed higher SOX9 
and Col II expression in chondrocytes from deep than from 
Fig. (4). Expression of CCND1 protein in fresh or frozen human knee superficial and deep articular cartilage chondrocytes stimulated by 
culturing with Dulbecco's Modified Eagle's Medium (DMEM) with 10% fetal bovine serum (FBS). Protein concentrations were measured 
using a NanoDropTM spectrophotometer and confirmed by western blot analysis. Data were normalized against the lowest value obtained for 
CCND1 protein expression levels, assigned the value of 1, and were measured as R.E.L. 
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superficial zone. During the isolation and cultivation of 
chondrocytes for ACI, certain problems may arise, leading to 
inadequate implantation of these cells, either because there is 
contamination or because the isolated cells do not 
proliferate. For additional security, some of the isolated 
chondrocytes must be cryopreserved. Previous studies [49] 
demonstrated that the survival and proliferation of 
chondrocytes were reduced after cryopreservation, 
particularly evident when the freezing rate was not carefully 
controlled (-1ºC/min to –40ºC; -2ºC/min to -60ºC; and -
5ºC/min to -150ºC). Our study analyzed the proliferative 
capacity of cryopreserved chondrocytes, using controlled 
freezing, from both superficial and deep cartilage biopsies. 
Stimulated frozen cells showed no significant difference in 
chondrogenic potential between chondrocytes of deep and 
superficial zone origin. In cryopreserved cells, in contrast to 
what was observed for fresh cells, there was an indication of 
increased proliferative capacity in superficial chondrocytes, 
compared to chondrocytes derived from deep biopsies, 
although the difference did not achieve statistical 
significance. An interesting theory that we draw from this 
study was that cryopreservation selects the most viable and 
most resistant, and therefore the highest quality 
chondrocytes, with the freezing and thawing process killing 
less viable cells. Our results indicate that cryopreservation 
equally affects chondrocytes from both superficial and deep 
cartilage biopsies. Both superficial and deep origin frozen 
chondrocyte populations seem to be homogeneous, showing 
no statistically significant differences in their proliferative 
capacity. In contrast, fresh chondrocytes from superficial and 
deep cartilage biopsies, not subjected to this selective 
process, were more heterogenous, suggested by the higher 
proliferative capability of the deep chondrocyte population. 
CONCLUSIONS 
 The highest rates of cell proliferation and chondrogenic 
potential of fresh chondrocytes were obtained from deep 
cartilage biopsies. For frozen chondrocytes, there were no 
significant differences in proliferative and chondrogenic 
capacity related to biopsy origin. These results indicate that both 
cartilage biopsy origin and chondrocyte cryopreservation affects 
the proliferative and chondrogenic potential of chondrocytes 
and, thus, their ability to regenerate cartilage. Consideration of 
chondrocyte origin and processing will enhance the success of 
cell therapy to repair focal articular cartilage injury. 
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